IceCure Medical (ICCM) Q1 2026 Earnings
ICCM·Reported May 12, 2026·Before market open
IceCure Medical reported Q1 2026 revenue of $911.0K (+25.7% YoY), missed analyst consensus of $1.3M by $433.3K. Diluted EPS came in at $-0.06 (+0.0% YoY), missed the $-0.03 consensus by $0.03.
Revenue
$911.0Kmissed by $433.3K
Consensus: $1.3MDiluted EPS
$-0.06missed by $0.03
Consensus: $-0.03
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2026 Earnings FAQ
Common questions about IceCure Medical's Q1 2026 earnings report.
IceCure Medical (ICCM) reported Q1 2026 earnings on May 12, 2026 before market open.
IceCure Medical reported revenue of $911.0K and diluted EPS of $-0.06 for Q1 2026.
Revenue missed the consensus estimate of $1.3M by $433.3K. EPS missed the consensus estimate of $-0.03 by $0.03.
Compared to the same quarter a year prior, revenue grew 25.7% from $725.0K a year earlier and diluted EPS grew 0.0% from $-0.06.